-The Hindu They seek waiver on some provisions of world agreements that regulate intellectual property rights to expedite steps to contain pandemic India and South Africa, in a formal submission to the World Trade Organization (WTO) on October 2, sought a waiver on certain provisions of the international agreements that regulate intellectual property rights to speed up efforts to prevent, treat and contain the COVID-19 pandemic. In the communication, the countries said there...
More »SEARCH RESULT
Total Matching Records found : 51
The encephalitis challenge -Priyanka Chaturvedi & Oommen C Kurian
-The Hindu There must be consensus among major political parties around vital issues like health Barely a month before the deaths of children in Gorakhpur in Uttar Pradesh, allegedly due to the disruption of oxygen supply in the BRD Medical College, the U.P. Health Minister had addressed a consultation in Lucknow organised by the Observer Research Foundation. He admitted that U.P.’s health system was in the “ICU”, and said he was trying...
More »Priming the polio fight -R Prasad
-The Hindu The global vaccine 'switch', from trivalent to bivalent OPV, has been recommended by the Strategic Advisory Group of Experts as a critical component of the polio endgame strategy Beginning Monday, April 25, India will stop using the oral polio vaccine (OPV) with all three strains of the poliovirus (type 1, type 2 and type 3) and instead use OPV vaccines with only two strains — type 1 and type 3....
More »Every birth, every mother, matters -Cyril Engmann
-The Hindu Business Line Timely interventions through medical innovations can transform the lives of mothers and children, not simply save them A couple of years ago, I was in a primary health centre delivery room in Shivgarh and saw a beaming mother with her three-hour-old baby girl happily feeding at the breast. Three hours earlier, this contented baby was born without a cry, still, and blue in colour. Fortunately, the midwife present,...
More »Patent plea on vaccine hits block
-The Telegraph New Delhi: International humanitarian agency Medecins Sans Frontieres has filed an application to block US pharmaceutical company Pfizer from obtaining a patent in India for a vaccine against pneumonia and allow Indian vaccine manufacturers to make low-cost versions. The patent opposition moved by MSF has claimed that Pfizer's patent application, which describes methods of conjugating 13 serotypes (strains) of the bacterium Streptococcus pneumoniae into a single carrier vaccine, does not...
More »
